Blueprint Medicines News Timeline Breakdown

BPMC -- USA Stock  

USD 70.73  1.04  1.49%

This is yet another view into Blueprint Medicines filtered headlines to help investors concentrate on Blueprint Medicines Corporation noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Blueprint Medicines headlines in addition to utilizing other more conventional financial analysis modules. Check also Blueprint Medicines Backtesting and Blueprint Medicines Hype Analysis.
news
August 1, 2018
Why The Heat Wave For US Pharma Could Continue This Month at www.investors.com 
View Story
wired  News
August 8, 2018
Exercise or conversion by Jeffrey Albers of 20000 shares of Blueprint Medicines subject to Rule 16b-3 at nysewired.com 
View Story
wired  News
August 13, 2018
What Investors Should Know Blueprint Medicines Corporation at nysewired.com 
View Story
Macroaxis News
August 17, 2018
Blueprint Medicines exotic insider transaction detected at MacroaxisInsider 
View Story
Macroaxis News
July 30, 2018
Exercise or conversion by Alfred Gilman of 800 shares of Regeneron Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
August 6, 2018
Sage Therapeutics Stock Declined While Morgan Stanley Decreased by 5.48 Million Its Stake Scholtz ... at enbulletin.com 
View Story
news
August 9, 2018
5 Biotech Stocks Offering Healthy Gains at www.investopedia.com 
View Story
news
August 14, 2018
TD Asset Management Inc. Purchases 9611 Shares of SAGE Therapeutics Inc at www.fairfieldcurrent.com 
View Story
news
August 1, 2018
Equity Focus Investors Focusing on Shares of Sage Therapeutics, Inc. as Company Makes ... at www.thecoinguild.com 
View Story
news
August 2, 2018
Tower International to pay 0.12 on Sep 7, 2018 Orbimed Advisors Has Decreased By 11.88 Million Its ... at kreviewer.com 
View Story
businessinsider News
August 6, 2018
Xencor Reports Second Quarter 2018 Financial Results at markets.businessinsider.com 
View Story
news
August 14, 2018
Sale by Paul Foster of 15496 shares of Xencor at flecha123.com 
View Story
news
July 30, 2018
BbT Increased American Express Position By 319269 Xencor Shorts Lowered By 20.58 at ztribune.com 
View Story
news
August 9, 2018
Shares in the News Investors Keen on Mirati Therapeutics, Inc. as it Makes Waves With Moves at www.thecoinguild.com 
View Story
news
August 14, 2018
Melvin Capital Management LP Has Upped Macys Holding Mirati Therapeutics Sentiment Is 1.76 at flecha123.com 
View Story
news
August 1, 2018
Analyst Stock Recommendations For Achaogen, Inc. , Mirati Therapeutics, Inc. at www.thewellesleysnews.com 
View Story
news
August 3, 2018
Palisade Asset Management Upped Its Verizon Communications Position Alder Biopharmaceuticals, Inc. ALDR ... at ztribune.com 
View Story
Macroaxis News
August 10, 2018
Acquisition by Paul Cleveland of 15000 shares of Alder Biopharmaceutica subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
August 17, 2018
Equity Watch Investors Taking a Second Look at Alder BioPharmaceuticals, Inc. After Recent Market ... at www.thecoinguild.com 
View Story
Equities News
July 31, 2018
Alder BioPharmaceuticals Inc. Soars 5.57 percent on July 31 at www.equities.com 
View Story
Macroaxis News
August 2, 2018
Sale by Browne L Daniel of 22800 shares of Revance Therapeutics at MacroaxisInsider 
View Story
news
August 8, 2018
Hot Stock on Spotlight Revance Therapeutics, Inc. at nysedaily.com 
View Story
wsj  News
August 15, 2018
Investors Are Circling Sientra, Inc. , Revance Therapeutics, Inc. , What Do the ... at www.ollanewsjournal.com 
View Story
news
July 30, 2018
Stock Watch Investors Keen on Revance Therapeutics, Inc. as it Makes Headlines With Moves at www.thecoinguild.com 
View Story
news
August 3, 2018
Texas Instruments Com Share Value Rose While Baltimore-Washington Financial Advisors Has Trimmed ... at endigest.com 
View Story
news
August 8, 2018
Venbio Select Advisor Has Lifted Its Tg Therapeutics Holding Blackrock Muniyield California Quality Fund ... at cardinalweekly.com 
View Story
Macroaxis News
August 15, 2018
TG Therapeutics exotic insider transaction detected at MacroaxisInsider 
View Story
news
July 31, 2018
TG Therapeutics, Inc. stock reveals return of -9.17 percent for the previous five trading days at www.analystrecommendation.com 
View Story
news
July 30, 2018
Stock Alert and Holding Pattern MacroGenics Inc Realized Volatility Hits An Inflection Point at news.cmlviz.com 
View Story
news
August 2, 2018
As Factset Research Share Price Declined, Holder Markel Has Trimmed Its Position Dafna Capital Management ... at ztribune.com 
View Story
news
August 10, 2018
Influential Analyst Rating Changes MacroGenics, Inc. , Hannon Armstrong Sustainable Infrastructure Capital ... at thewellesleysnews.com 
View Story
news
July 27, 2018
-1.20 EPS Expected for MacroGenics, Inc. at floridarecorder.com 
View Story

Did you try this?

Run Piotroski F Score Now
   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Piotroski F Score

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Blueprint Medicines and Regeneron Pharmaceuticals. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Blueprint Medicines Backtesting and Blueprint Medicines Hype Analysis. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.